Hepatitis B and d Protocols : Immunology Model Systems, and Clinical Studies (Methods in Molecular Medicine) 〈2〉

個数:

Hepatitis B and d Protocols : Immunology Model Systems, and Clinical Studies (Methods in Molecular Medicine) 〈2〉

  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合、分割発送となる場合がございます。
    3. 美品のご指定は承りかねます。
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版/ページ数 600 p.
  • 言語 ENG
  • 商品コード 9781588291080
  • DDC分類 616.362301

Full Description

Despite the availability of an effective vaccine, there are still 400 million people, worldwide who are chronically infected with hepatitis B virus (HBV). For them, the vaccine, as currently applied, has no value. Given the possible consequences of HBV infection, the number of those chronically infected with HBV presents an enormous public health challenge. For example, the major etiology of hepatocellular carcinoma (HCC) is chronic infection with HBV. Although fifth in cancer incidence, worldwide, HCC/liver cancer is the third leading cause of cancer death. The high mortality as- ciated with HCC arises because the disease is often detected late and is unresponsive to treatment. The number of deaths caused by PHCC is expected to rise over the next 20 years. Those chronically infected with HBV have a life risk of death to HCC of between 10 and 25%. Even the limited efficacy of drugs for the treatment of chronic HBV helps underscore the point that this disease is responsive to therapy. Drugs that target the polymerase (e. g. , hepsera and lamivudine) and interferon alpha represent two distinct strategies and show that both conventional antiviral and immunothe- peutic approaches can be used in management. However, the current inventory of therapeutics is inadequate. Interferon alpha is of limited value, only parenterally ava- able, and fraught with adverse reactions.

Contents

Part I. Viral-Specific Immunological and Other Host Responses

Studying Host Immune Responses Against Duck Hepatitis B Virus Infection
Darren S. Miller, Edward M. Bertram, Catherine A. Scougall, Ieva Kotlarski, and Allison R. Jilbert

Measurement of Cell-Mediated Immune Response in Woodchucks
Stephan Menne and Paul J. Cote

Study of Liver-Specific Expression of Cytokines During Woodchuck Hepatitis Virus Infection
Mengji Lu and Michael Roggendorf

Induction of Anti-Hepatitis B Virus Immune Responses Through DNA Immunization
Michael Geissler, Robert Weth, Christian F. Grimm, Dörte Ortmann, and Hubert E. Blum

Monitoring Gene Expression Using DNA Microarrays During Hepatitis B Virus Infection
Michael R. Beard and Stephen Locarnini

Determination of Hepatitis B Virus-Specific CD8+ T-Cell Activity in the Liver
Michelina Nascimbeni and Barbara Rehermann

Determining the Precursor Frequency of HBV Nucleocapsid Antigen-Specific T Cells
Jennifer A. Waters and Howard C. Thomas

Detection and Characterization of Virus-Specific CD8+ T Cells Using the Tetramer Approach
Xiao-Song He and Harry B. Greenberg

In Vitro Analysis of Hepatitis B Virus Specific CD4+ T Cells
Shilpa Chokshi and Nikolai V. Naoumov

Induction of Humoral and Cellular Immune Responses to Hepatitis Delta Virus Through DNA Immunizaiton in BALB/c Mice
Ren-Shiang Lee, Shih-Jer Hsu, Li-Rung Huang, Hui-Lin Wu, Shiou-Lin Lin, Ding-Shinn Chen, and Pei-Jer Chen

Part II. In Vitro and In Vivo Models

Infection of Primary Chimpanzee Hepatocytes with Recombinant Hepatitis D Virus Particles: A Surrogate Model for Hepatitis B Virus
Azeneth Barrera and Robert E. Lanford

Study of the Endocytosis and Intracellular Localization of Subviral Particles of Hepatitis B Virus in Primary Hepatocytes
Dieter Glebe and Wolfram H.Gerlich

The Tupaia Model for the Study of Hepatitis B Virus: Direct Infection and HBV Genome Transduction of Primary Tupaia Hepatocytes
Fritz von Weizsäcker, Josef Köck, Sabine MacNelly, Shaotang Ren, Hubert E. Blum, and Michael Nassal

Delivery of Hepatitis B Virus Therapeutic Agents Using Asialoglycoprotein Receptor-Based Liver-Specific Targeting
Masayoshi Konishi, Catherine H. Wu, and George Y. Wu

Woodchuck Hepatitis Virus Hepatocyte Culture Models
Norma D. Churchill and Tomasz I. Michalak

Duck Hepatitis B Virus Primary Hepatocyte Culture Model
Olivier Hantz and Fabien Zoulim

Enhancement of Infection of HepG2 Cells in Culture by Predigestion of Hepadnavirus with V8 Protease
Xuanyong Lu and Timothy M. Block

Construction of Recombinant Adenoviruses that Produce Infectious Hepatitis B Virus
Martin Sprinzl, Jérôme Dumortier, and Ulrike Protzer

Baculovirus-Mediated Gene Transfer for the Study of Hepatitis B Virus
Harriet C. Isom, Ayman M. Abdelhamed, John P. Bilello, and Thomas G. Miller

Transgenic Hepatitis B Virus Mouse Model in the Study of Chemotherapy
John D. Morrey

Transplantation of Human Hepatocytes in Immunodeficient UPA Mice: A Model for the Study of Hepatitis B Virus
Jörg Petersen, Martin R. Burda, Maura Dandri, and Charles E. Rogler

Duck Hepatitis B Virus Model in the Study of Hepatitis B Virus
Lucyna Cova and Fabien Zoulim

Hepatitis B Virus Transgenic Severe Combined Immunodeficient Mouse Model of Acute and Chronic Liver Disease
Mark A. Feitelson, Jonathan D. Larkin, and Raymond F. Schinazi

The Chimpanzee Model: Contributions and Considerations for Studies of Hepatitis B Virus
Pascal Gagneux and Elaine A. Muchmore

Hepatitis B in Liver Transplant Recipients as a Special Model of Antiviral Drug Development
Robert G. Gish and Adil